Hikma to market Ferinject for Vifor in MENA

Hikma Pharmaceuticals has entered into a licensing and distribution agreement to market Ferinject (ferric carboxymaltose), Vifor Pharma's intravenous iron deficiency treatment, in the Middle East and North African (MENA) region.